Scaffold Technology Market Size, Share, Opportunities, And Trends By Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds), By Disease (Orthopedics, Musculoskeletal, & Spine, Cancer, Skin & Integumentary, Dental, Cardiology & Vascular, Neurology, Urology, GI, Gynecology, Others), By Application (Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery, Others), By End-Use (Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers, Others), And By Geography - Forecasts From 2023 To 2028

The global scaffold technology market is estimated to grow at a CAGR of 13.57% during the forecast period.

Scaffold technology is used especially in tissue engineering, regenerative medicine, and drug discovery. Scaffolds are three-dimensional constructs that give mechanical support and a favourable environment for cell development in the field of tissue engineering. They present potential solutions for tissue regeneration and repair. Made of a variety of materials, these scaffolds imitate the extracellular matrix found in nature, providing a surface on which cells may cling and multiply. Scaffold technology is used in drug development to generate molecular frameworks that may be altered to produce a variety of compounds for testing, which expedites the process of finding new drugs.

Growth drivers for the scaffold technology market

Major growth drivers for the scaffold technology market are the increased need for 3D cellular models for use in biological research and translational studies. The scaffold technology market is expanding as the 3D cell culture is rising due to difficulties in the drug development process. The study of virology and epidemiology, the creation of in vitro model systems, and the search for effective anti-infective therapies all make substantial use of tissue engineering which fuels the scaffold technology market growth.

Rising utilization of scaffold technology in 3D cell culture

For 3D cell culture, scaffolds are significantly used. Scaffolds enable the movement of oxygen, nutrients, and waste because of their porosity. Cells can therefore multiply and move around the scaffold web before adhering to it. The maturing cells interact with one another as they grow and eventually transform into structures that are connected to the tissues from which they originally came. This growing application of scaffolding in 3D cell culture is expected to fuel the scaffold technology market growth.

Advancements in scaffold technology

Technological breakthroughs in scaffolding have influenced revolutionary advances in regenerative medicine and tissue engineering. The creation of scaffolds has been transformed by the combination of 3D printing with bioprinting, which allows for exact control over the arrangement of cells and structure. These advancements are major growth drivers for the scaffold technology market. Solvent casting, solution blow spinning, particle leaching, self-assembly, gas foaming, fiber mesh, and lithography are some of the processes included in scaffold technology.

Increasing utilization of scaffold technology in the treatment of cancer

Several biocompatible polymers that have received FDA approval have been established to create a variety of 3D scaffolds to treat cancer recurrence, which is a major driver for the scaffold technology market growth. For choosing a polymer, the type of tumour microenvironment, metastasis, chemo medicines, and immunotherapeutics are analyzed for various qualities such as high surface volume, high porosity, and tuneable mechanical properties. Moreover, 3D scaffolds are of interest for cancer immunotherapy and are further upsurging the scaffold technology market growth.

Nano-fiber scaffold is predicted to hold a significant market share

The use of nano-fiber scaffolds is expanding due to their growing use in tissue engineering and regeneration applications. For instance, scientists around the globe are focusing on research related to nanofiber scaffold usage in the creation of nerve tissue. Nano-sized structures that can serve as an extracellular matrix for cellular transformation are made using techniques like electrospinning. Electrospinning provides several benefits such as simplicity of use, affordability, and high flexibility, which can accelerate the scaffold technology market growth.

Rising government initiatives are predicted to fuel the market

The scaffold technology market is anticipated to grow due to various government initiatives. For instance, in June 2023, the Indian Drugs Controller gave their permission to the first locally created tissue engineering scaffold made from mammalian organs, a Class D biomedical device that may quickly and affordably treat skin lesions with little scarring. The Department of Science and Technology (DST) and Sree Chira Triunal Institute for Medical Sciences and Technology, collaborated to meet all the legal requirements to form the Central Drugs Standard Control Organization.

North America’s scaffold technology market is anticipated to grow at a steady pace

The scaffold technology market is predicted to grow at a steady pace in North America. This can be attributed to a rise in research on stem cells and regenerative medicine, increased funding for expanding the applications of these technologies, and a well-established healthcare system. Furthermore, researchers have also improved 3D micro scaffold technology, which helps reprogrammed neural stem cells and supports connections between neurons. Instead of injecting individual cells, these networks exhibited greater brain survival in mice. Additionally, stem cell biologists and biomaterial specialists collaborated in their recent work supported by the National Institute of Biomedical Imaging and Bioengineering.

Growth in major market players focuses on product innovation

For tissue regeneration, many businesses are creating novel 3D bio-printed customized scaffolds. For instance, 3D Systems and United Therapeutics Corporation collaborated to create cutting-edge 3D-printed organ technology in June 2022. Moreover, nanofiber scaffolds are gaining popularity because of their high surface area-to-volume ratio and capacity to replicate the fibrous structure of the extracellular matrix in nature. Additionally, in November 2022, Gelomics and Rousselot announced a cobranding partnership that used Gelomics' LunaGel 3D Tissue Culture System and Rousselot Biomedical's X-Pure GelMA (gelatin methacryloyl) extracellular matrix.

Market Key Developments

• In June 2023, The National Institutes of Health (NIH) awarded RevBio, Inc. a USD 2 million grant for the creation of their innovative dental adhesive bone scaffold product.
• In April 2023, to produce hydrogel scaffolds and conduct research and development for organ-on-a-chip technology to improve drug discovery and development, Systemic Bio constructed a new lab in Texas, the United States.
• In August 2022, Conmed announced the acquisition of Biorez, a provider of bio-inductive scaffolds, to increase its selection of soft tissue healing products for use in sports medicine.

Scaffold Technology Market Scope:

 

Report Metric	Details
Growth Rate	CAGR of 13.57% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Type, Disease, Application, End-Use, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Thermo Fisher Scientific, Inc., Merck KGaA, REPROCELL Inc., 3D Biotek LLC, Becton, Dickinson, and Company, Medtronic, Matricel GmbH, Akron Biotech, Avacta Life Sciences Limited., Vericel Corporation
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Type
  • Hydrogels
  • Polymeric Scaffolds
  • Micropatterned Surface Microplates
  • Nanofiber Based Scaffolds
• By Disease
  • Orthopedics, Musculoskeletal, & Spine
  • Cancer
  • Skin & Integumentary
  • Dental
  • Cardiology & Vascular
  • Neurology
  • Urology
  • GI, Gynecology
  • Others
• By Application
  • Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
  • Drug Discovery
  • Others
• By End-User
  • Biotechnology & Pharmaceutical Organizations
  • Research Laboratories & Institutes
  • Hospitals & Diagnostic Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

---

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. SCAFFOLD TECHNOLOGY MARKET, BY TYPE

5.1. Introduction

5.2. Hydrogels

5.3. Polymeric Scaffolds

5.4. Micropatterned Surface Microplates

5.5. Nanofiber Based Scaffolds

6. SCAFFOLD TECHNOLOGY MARKET, BY DISEASE

6.1. Introduction

6.2. Orthopedics, Musculoskeletal, & Spine

6.3. Cancer

6.4. Skin & Integumentary

6.5. Dental

6.6. Cardiology & Vascular

6.7. Neurology

6.8. Urology

6.9. GI, Gynecology

6.10. Others

7. SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION

7.1. Introduction

7.2. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering

7.3. Drug Discovery

7.4. Others

8. SCAFFOLD TECHNOLOGY MARKET, BY END-USE 

8.1. Introduction

8.2. Biotechnology & Pharmaceutical Organizations

8.3. Research Laboratories & Institutes

8.4. Hospitals & Diagnostic Centers

8.5. Others

9. SCAFFOLD TECHNOLOGY MARKET, BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Spain

9.4.5. Others

9.5. The Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. Japan

9.6.2. China

9.6.3. India

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Emerging Players and Market Lucrativeness

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES 

11.1. Thermo Fisher Scientific, Inc.

11.2. Merck KGaA

11.3. REPROCELL Inc.

11.4. 3D Biotek LLC

11.5. Becton, Dickinson, and Company

11.6. Medtronic

11.7. Matricel GmbH

11.8. Akron Biotech

11.9. Avacta Life Sciences Limited.

11.10. Vericel Corporation

Thermo Fisher Scientific, Inc.

Merck KGaA

REPROCELL Inc.

3D Biotek LLC

Becton, Dickinson, and Company

Medtronic

Matricel GmbH

Akron Biotech

Avacta Life Sciences Limited.

Vericel Corporation